---
figid: PMC11771717__cm9-138-278-g001
figtitle: KRAS signaling pathway functions differently in normal cells compared to
  cancer cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11771717
filename: cm9-138-278-g001.jpg
figlink: /pmc/articles/PMC11771717/figure/F1/
number: F1
caption: 'The KRAS signaling pathway functions differently in normal cells compared
  to cancer cells. (A) In normal cells, the activity of the KRAS protein is regulated
  by upstream RTKs such as EGFR, FGFR, and PDGFR. The levels of activated KRAS are
  determined by a balance between GTP hydrolysis and nucleotide exchange. Upon activation,
  KRAS initiates downstream pathways that regulate cell growth and proliferation.
  (B) In cancer cells, KRAS mutation leads to spontaneous activation of KRAS protein
  effects. This aberrant activation promotes cell proliferation and migration, ultimately
  contributing to tumorigenesis and tumor progression. AKT: Protein kinase B; EGFR:
  Epidermal growth factor receptor; ERK: Extracellular signal-related kinase; FGFR:
  Fibroblast growth factor receptor; GAP: GTP-activating protein; GDP: Guanosine diphosphate;
  GEF: Guanosine exchange factor; GRB2: Growth factor receptor-bound protein 2; MEK:
  Mitogen-activated protein kinase/ERK kinase; GTP: Guanosine triphosphate; KRAS:
  Kirsten-RAS; PDGFR: Platelet-derived growth factor receptor; PI3K: Phosphoinositide
  3-kinase; PIP2: Phosphatidylinositol diphosphate; PIP3: Phosphatidylinositol triphosphate;
  RTKs: Receptor tyrosine kinases; SHP2: Src homology 2 domain-containing protein
  tyrosine phosphatase; SOS: Son of sevenless'
papertitle: Role of silent mutations in KRAS-mutant tumors
reftext: Jun Lu, et al. Chin Med J (Engl). 2024 Dec 10;138(3).
year: '2024'
doi: 10.1097/CM9.0000000000003405
journal_title: Chinese Medical Journal
journal_nlm_ta: Chin Med J (Engl)
publisher_name: Wolters Kluwer Health
keywords: KRAS mutations | Silent mutation | Tumor | Biological characteristics
automl_pathway: 0.8647962
figid_alias: PMC11771717__F1
figtype: Figure
redirect_from: /figures/PMC11771717__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11771717__cm9-138-278-g001.html
  '@type': Dataset
  description: 'The KRAS signaling pathway functions differently in normal cells compared
    to cancer cells. (A) In normal cells, the activity of the KRAS protein is regulated
    by upstream RTKs such as EGFR, FGFR, and PDGFR. The levels of activated KRAS are
    determined by a balance between GTP hydrolysis and nucleotide exchange. Upon activation,
    KRAS initiates downstream pathways that regulate cell growth and proliferation.
    (B) In cancer cells, KRAS mutation leads to spontaneous activation of KRAS protein
    effects. This aberrant activation promotes cell proliferation and migration, ultimately
    contributing to tumorigenesis and tumor progression. AKT: Protein kinase B; EGFR:
    Epidermal growth factor receptor; ERK: Extracellular signal-related kinase; FGFR:
    Fibroblast growth factor receptor; GAP: GTP-activating protein; GDP: Guanosine
    diphosphate; GEF: Guanosine exchange factor; GRB2: Growth factor receptor-bound
    protein 2; MEK: Mitogen-activated protein kinase/ERK kinase; GTP: Guanosine triphosphate;
    KRAS: Kirsten-RAS; PDGFR: Platelet-derived growth factor receptor; PI3K: Phosphoinositide
    3-kinase; PIP2: Phosphatidylinositol diphosphate; PIP3: Phosphatidylinositol triphosphate;
    RTKs: Receptor tyrosine kinases; SHP2: Src homology 2 domain-containing protein
    tyrosine phosphatase; SOS: Son of sevenless'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PDGFRB
  - PDGFRA
  - GRB2
  - PTPN11
  - XYLT2
  - SOS1
  - SOS2
  - ARHGEF2
  - SLC2A4RG
  - MTG1
  - KRAS
  - NRAS
  - RASA1
  - RGS6
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GTP
  - GDP
  - GAP
  - MEK
  - protein
  - Cancer
---
